Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) Debt to Equity (2016 - 2021)

GeoVax Labs' Debt to Equity history spans 11 years, with the latest figure at $0.0 for Q1 2021.

  • Quarterly results put Debt to Equity at $0.0 for Q1 2021, up 104.43% from a year ago — trailing twelve months through Mar 2021 was $0.0 (up 104.43% YoY), and the annual figure for FY2020 was $0.0, up 108.9%.
  • Debt to Equity for Q1 2021 was $0.0 at GeoVax Labs, down from $0.0 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.0 in Q3 2020 to a low of -$0.38 in Q1 2018.
  • The 4-year median for Debt to Equity is -$0.03 (2019), against an average of -$0.07.
  • Peak annual rise in Debt to Equity hit 108.9% in 2020, while the deepest fall reached 917.53% in 2020.
  • Year by year, Debt to Equity stood at -$0.04 in 2018, then soared by 55.31% to -$0.02 in 2019, then soared by 108.9% to $0.0 in 2020, then tumbled by 61.78% to $0.0 in 2021.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.0, $0.0, and $0.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.